10.1182/blood-2013-06-506741 - Infusion of donor-derived CD19-redire...

This document has been corrected

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

10.1182/blood-2013-06-506741

Published Online: 2013-10-24

Journal: Blood•Publisher: American Society of Hematology

Authors: A. John Barrett•Adrian P. Gee•Bambi J. Grilley•Barbara Savoldo•Carlos A. Ramos•Catherine M. Bollard•Chitra M. Hosing•Cliona M. Rooney•Conrad Russell Y. Cruz•Elizabeth J. Shpall•Enli Liu•George Carrum•Gianpietro Dotti•Helen E. Heslop•Kenneth P. Micklethwaite•Malcolm K. Brenner•Oumar Diouf•Rammurti T. Kamble•Robert A. Krance•Sawa Ito•Sharon Lam•Stephanie Ku•Zhuyong Mei

This document has been corrected

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

10.1182/blood-2013-06-506741

Published Online: 2013-10-24

Journal: Blood

NOW

2014-05-22•Erratum

Cruz CRY, Micklethwaite KP, Savoldo B, et al. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood. 2013;122(17):2965-2973.

10.1182/blood-2014-04-570481

* information provided by CrossRef

2014-05-22•Erratum

10.1182/blood-2014-04-570481

* information provided by CrossRef

2013-10-24•Published

2014-05-22•Erratum

10.1182/blood-2014-04-570481

* information provided by CrossRef

This document has been corrected

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

10.1182/blood-2013-06-506741

Published Online: 2013-10-24

Journal: Blood•Publisher: American Society of Hematology